Internal Medicine, Cardiovascular Disease · Fresno, CA
NPI
1780671131
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1313 E Herndon Ave, Ste 203
Fresno, CA, 93720
Phone (559) 439-6808
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
20,797 services
Medicare patients, 2024
2,878
Average age 77
Drug cost, 2024
$2.9M
15,059 prescriptions
Company payments, 2025
$2,408
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dalpinder Sandhu was code 99214 (office e&m - established), 4,737 times for 2,218 patients. In total Dalpinder Sandhu billed 20,797 services in 109 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 4,737 | 2,218 | $96.10 | $455K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 2,920 | 719 | $5.43 | $16K |
| 93000 Electrocardiogram | Office | 1,702 | 1,519 | $10.93 | $19K |
| 93306 Echocardiography (TTE/TEE) | Office | 1,419 | 1,337 | $154.76 | $220K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 1,254 | 622 | $409.14 | $513K |
| 93015 Electrocardiogram | Office | 847 | 831 | $57.47 | $49K |
| 99213 Office E&M - Established | Office | 682 | 583 | $69.94 | $48K |
| 93298 External Electrocardiographic Monitoring | Office | 678 | 158 | $83.85 | $57K |
| 78492 Myocardial Perfusion Scan | Office | 626 | 621 | $1,218.45 | $763K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 544 | 535 | $151.85 | $83K |
| 93010 Electrocardiogram | Facility | 477 | 378 | $6.23 | $2,971 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 436 | 218 | $36.85 | $16K |
| 99152 Anesthesia | Facility | 431 | 367 | $9.32 | $4,018 |
| 93567 Percutaneous Transcatheterization | Facility | 319 | 284 | $27.66 | $8,822 |
| 93458 Percutaneous Transcatheterization | Facility | 274 | 243 | $159.67 | $44K |
By year: 2022 $2.4M for 17,967 services; 2023 $2.7M for 17,918 services; 2024 $2.8M for 20,797 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dalpinder Sandhu prescribed most often to Medicare patients was Metoprolol Succinate, with 1,208 prescriptions and refills. In total Dalpinder Sandhu wrote 15,059 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,208 | 3,377 | 385 | $20K |
| Clopidogrel Clopidogrel Bisulfate | 1,003 | 2,871 | 353 | $13K |
| Eliquis Apixaban | 929 | 2,189 | 269 | $1.2M |
| Atorvastatin Calcium Generic | 807 | 2,340 | 254 | $7,591 |
| Rosuvastatin Calcium Generic | 713 | 2,092 | 250 | $11K |
| Furosemide Generic | 642 | 1,755 | 231 | $3,436 |
| Amlodipine Besylate Generic | 641 | 1,826 | 201 | $4,757 |
| Spironolactone Generic | 628 | 1,816 | 209 | $6,706 |
| Losartan Potassium Generic | 542 | 1,530 | 173 | $6,462 |
| Repatha Sureclick Evolocumab | 510 | 873 | 111 | $491K |
| Carvedilol Generic | 486 | 1,370 | 157 | $4,377 |
| Ezetimibe Generic | 464 | 1,327 | 151 | $14K |
| Bisoprolol Fumarate Generic | 347 | 994 | 99 | $11K |
| Lisinopril Generic | 332 | 980 | 111 | $2,741 |
| Prasugrel Hcl Generic | 273 | 761 | 93 | $28K |
Brand drugs: 2,575 claims; generic drugs: 12,484 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dalpinder Sandhu $2,408 ($2,408 in general payments such as food, travel and fees) from 10 companies. The largest payer was Philips North America LLC with $1,250.
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC PHG | 8 | $1,250 |
| Abbott Laboratories ABT | 15 | $462 |
| Amgen Inc. AMGN | 18 | $212 |
| Abiomed JNJ | 3 | $186 |
| Shockwave Medical, Inc JNJ | 2 | $156 |
| Corcept Therapeutics CORT | 2 | $63.75 |
| Boston Scientific Corporation BSX | 1 | $26.35 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.54 |
| Pfizer Inc. PFE | 1 | $16.95 |
| Esperion Therapeutics, Inc. ESPR | 1 | $14.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.